Pre-made Raxibacumab benchmark antibody (Whole mAb, anti-anthrax protective antigen (PA) [Bacillus anthracis] therapeutic antibody) for drug discovery and mechanism of action (MOA) research

Cat No.: GMP-Bios-INN-968

Anti-anthrax protective antigen (PA) [Bacillus anthracis] therapeutic antibody (Pre-made Raxibacumab biosimilar, Whole mAb) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Raxibacumab [1] is a human monoclonal antibody intended for the prophylaxis and treatment of inhaled anthrax. Its efficacy has been proven in rabbits and monkeys.[2] In December 212 raxibacumab was approved in the United States for the treatment of inhalational anthrax due to Bacillus anthracis in combination with appropriate antibacterial drugs, and for prophylaxis of inhalational anthrax when alternative therapies are not available or are not appropriate.[3][4]

Order information

* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-INN-968-1mg 1mg 3090
GMP-Bios-INN-968-10mg 10mg Inquiry
GMP-Bios-INN-968-100mg 100mg Inquiry
GMP-Bios-INN-968-xmg ≥100mg Inquiry
Shipping Cost: 760.00


Products Name (INN Index) Pre-Made Raxibacumab Biosimilar, Whole Mab: Anti-Anthrax Protective Antigen (Pa) [Bacillus Anthracis] therapeutic antibody
INN Name Raxibacumab
Targetanthrax protective antigen (PA) [Bacillus anthracis]
FormatWhole mAb
Species Reactivityhuman
CH1 IsotypeIgG1 - lambda
VD LCIgG1 - lambda
Highest_Clin_Trial (Jan '20)
Est. Status
100% SI Structure
99% SI Structure
95-98% SI Structure
Year Proposed
Year Recommended
CompaniesGlaxoSmithKline (Brentford UK) / Human Genome Sciences Inc. (HGSI) (Rockville MD USA)
Conditions Approved
Conditions Active
Conditions Discontinued
Development TechCambridge Antibody Technology (CAT) human antibody phage display library